Baxter International Inc (BAX) 71.14 $BAX Final Glance:

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Baxter International Inc (BAX) 71.14 $BAX

Final Glance: Pharmaceuticals companies
AP - Fri Apr 24, 7:08PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:
JNJ: 101.08 (+0.62), BAX: 71.14 (-0.37), PFE: 35.27 (-0.09), BMY: 65.80 (-0.20)

Final Glance: Medical Devices companies
AP - Fri Apr 24, 7:08PM CDT
NEW YORK (AP) — Shares of some top medical devices companies were mixed at the close of trading:
ZMH: 118.76 (+0.19), JNJ: 101.08 (+0.62), BAX: 71.14 (-0.37)

Midday Glance: Pharmaceuticals companies
AP - Fri Apr 24, 12:36PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 1 p.m.:
JNJ: 101.08 (+0.62), BAX: 71.14 (-0.37), PFE: 35.27 (-0.09), BMY: 65.80 (-0.20)

Midday Glance: Medical Devices companies
AP - Fri Apr 24, 12:36PM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 1 p.m.:
ZMH: 118.76 (+0.19), JNJ: 101.08 (+0.62), BAX: 71.14 (-0.37)

Baxter (BAX) Beats Q1 Earnings Estimates, Sales Down Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 24, 11:30AM CDT
Baxter International Inc (BAX) reported first-quarter 2015 adjusted earnings of $1.00 per share, which surpassed the Zacks Consensus Estimate by 12 cents.
BAX: 71.14 (-0.37), NKTR: 10.77 (-0.29), CHRS: 23.52 (-0.88), MCO: 107.50 (-0.26)

Early Glance: Pharmaceuticals companies
AP - Fri Apr 24, 9:55AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
JNJ: 101.08 (+0.62), BAX: 71.14 (-0.37), PFE: 35.27 (-0.09), BMY: 65.80 (-0.20)

Early Glance: Medical Devices companies
AP - Fri Apr 24, 9:55AM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
ZMH: 118.76 (+0.19), JNJ: 101.08 (+0.62), BAX: 71.14 (-0.37)

Baxter
at Investor's Business Daily - Thu Apr 23, 5:31PM CDT
Baxter (BAX), a maker of medical devices and drugs, reported Q1 EPS that fell 16% on int'l currency weakness to $1, but that topped views for 88 cents. Sales fell 5% to $3.764 bil, better than the $3.696 forecast. Shares rose 1.6% to 71.51.
BAX: 71.14 (-0.37)

Baxter International Inc.: Where a Decline Is a Win
Brian Orelli, The Motley Fool - Motley Fool - Thu Apr 23, 4:25PM CDT
Baxter 's revenue and earnings fell year over year, but shares are up today because the decline wasn't nearly as bad as investors had feared. Sales declined 2% year over year to $3.76 billion in the first quarter, but all of the decline and then...
BIIB: 401.71 (-28.57), BAX: 71.14 (-0.37)

Baxter International Rises 1.61% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Thu Apr 23, 4:08PM CDT
Baxter International (NYSE:BAX) traded in a range yesterday that spanned from a low of $70.02 to a high of $72.07. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of $70.68 on volume of 4.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BAX: 71.14 (-0.37)

After Yesterday's Rally of 1.61% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Thu Apr 23, 4:07PM CDT
Baxter International (NYSE:BAX) traded in a range yesterday that spanned from a low of $70.02 to a high of $72.07. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of $70.68 on volume of 4.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BAX: 71.14 (-0.37)

Baxter International (BAX) Earnings Report: Q1 2015 Conference Call Transcript
at The Street - Thu Apr 23, 2:15PM CDT
The following Baxter International (BAX) conference call took place on April 23, 2015, 08:30 AM ET. This is a transcript of that earnings call:
BAX: 71.14 (-0.37)

Baxter International's (BAX) CEO Bob Parkinson on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Apr 23, 1:29PM CDT

BAX: 71.14 (-0.37)

Baxter Reports First Quarter Financial Results That Exceed Guidance
M2 - Thu Apr 23, 11:40AM CDT
Baxter International Inc. (NYSE:BAX) today reported first quarter financial results that exceeded the company's previously issued guidance. Baxter reported first quarter net income of $430 million and earnings per diluted share of $0.78, compared to net income of $556 million and earnings per diluted share of $1.01 in the same period last year. First quarter 2015 results include net after-tax special items totaling $120 million (or $0.22 per diluted share), primarily for intangible asset amortization, costs associated with the company's planned separation and the integration of its Gambro AB acquisition, partially offset by a benefit related to the reversal of certain business optimization reserves. First quarter 2014 results included net after-tax charges totaling $96 million (or $0.18 per diluted share).
BAX: 71.14 (-0.37)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Omneky Outshines Competitors in AI Ad Scoring

Updated Category News Views 24

Brewing a better ad with AI isn't just about the model you plug in—it's about the wizardry wrapping around it. Omneky's latest caper in the AI advertising game has snagged the spotlight, pulling a hearty 8.8 taste score on a recent TasteBench comparison. That's not a minor tweak, folks, but a whopping 1.2-point lead over the shadow-chasing curves of the next...

Continue Reading
Laars Welcomes Women in Manufacturing to Facility Tour

Updated Category News Views 6

Opening Doors and Minds in Manufacturing On October 15, Laars Heating Systems throws wide open its Rochester, N.H., facility to a group that's rewriting the rulebook: women in manufacturing. It's not just another day in the life of assembly lines and engineering desks, folks. This is about giving a platform to those often sidelined in the field of boilers and water...

Continue Reading
New Data on SKYRIZI Offers Hope for Crohn's Patients

Updated Category News Views 7

Treating Crohn's: New Hope on the Horizon Folks, let me tell you, the landscape for treating Crohn's disease just got a bit more interesting. AbbVie's Phase 3 AFFIRM study has brought some attention-grabbing data on the table, showcasing the potential of their drug, SKYRIZI® (risankizumab-rzaa). This ain't just another run-of-the-mill study; these results could be a...

Continue Reading
Special Needs Group Partners with MAST to Enhance Accessibility

Updated Category News Views 15

Accessible Travel Takes the Spotlight Ah, the travel biz—just when you think you’ve got it all figured out, along comes a partnership like this to shake things up. Special Needs Group, the big cheese in mobility and medical equipment rentals, is teaming up with MAST Travel Network. Together, they're rolling out initiatives to make the world a bit more accessible, even...

Continue Reading
Paradigm Therapeutics: A Beacon in Rare Diseases

Updated Category News Views 2

A Step Towards Recognition You know the old saying: innovation never sleeps. Well, Paradigm Therapeutics seems to have taken that to heart. The company's embarked on a peculiar yet promising journey with SD-101 (Zorblesia™), and here they are, basking in the glow of another nomination for the 2026 Prix Galien USA "Best Start-Up" award. It’s their second shot at this...

Continue Reading
Canada and Ukraine Fortify Defense with UGV Partnership

Updated Category News Views 7

New Defense Fronts: Canada and Ukraine Join Forces October 13, 2026, marks an important day in Ottawa's defense narrative with Dominion Dynamics and Ukraine's TENCORE kicking off a robust partnership. They're not just collaborating; they're plugging into each other's strengths to build TerMIT uncrewed ground vehicles (UGVs) on Canadian soil. These aren't gizmos you find...

Continue Reading
Fluence Energy Faces Major Lawsuit Amid $3B Loss

Updated Category News Views 11

Securities Class Action: A Storm Brewing Just when you think you've got a grip on the market, a sharp right hook can come out of nowhere. Fluence Energy (NASDAQ:FLNC) is dealing with one of those punches now, getting dragged into the courtroom over claims they fudged financial lines. They hail innovation in energy storage, but shareholders are left shaking in their boots...

Continue Reading
Partner Valuation Advisors Bolsters Team with Eichman

Updated Category News Views 2

Eichman Joins Partner Valuation Advisors as MD Turns out the buzz in real estate appraisal isn’t just about property values these days; it's about who's valuing them. Just ask Partner Valuation Advisors, who are realigning their chess pieces by bringing seasoned pro Justin Eichman, MAI, on board as Managing Director. Talk about playing your cards right. A Heavyweight in...

Continue Reading
Montesodi 2023: A Fresh Chapter in Chianti Excellence

Updated Category News Views 7

A Glass Filled with History and Nature's Whimsy When you pour a glass of Montesodi 2023, you’re not just tasting wine but a story—a saga that blends Tuscany’s rich vineyard history with last year's unpredictable weather. Marchesi Frescobaldi, a name that’s seen it all over its thousand years, has once again shown us how resilience and tradition can marry with...

Continue Reading
Quark Baby's Milk Warmer Debut at Vancouver & Dubai

Updated Category News Views 15

An Unconventional Pitch for Baby Gear Quark Baby is strutting its stuff not just in Vancouver but all the way in Dubai. Yeah, we're talking about a milk warmer hitting two major expos. What's the deal with an award-winning brand from Vancouver making so much noise? From October 17-18, they're home-court at The Baby Show Vancouver, and by October 22-24, they're in Dubai at...

Continue Reading

Top 5 Most Recently Viewed Articles

Seadrill and Petrobras Unite for Major $498 Million Deal

Updated Category News Views 246

Seadrill Secures Major Contract with Petrobras HAMILTON, Bermuda - Seadrill Limited (NYSE: SDRL), an offshore drilling contractor with a market capitalization of $2.46 billion and a trading price of $37.31, has successfully won a crucial contract with Brazilian oil giant Petrobras for its ultra-deepwater drillship, West Tellus. This significant agreement emerged from a...

Continue Reading
Investigation Launched into Acadia Healthcare Company’s Practices

Updated Category News Views 143

Acadia Healthcare Company Under Investigation Law Offices of Howard G. Smith has announced that it is conducting an investigation on behalf of Acadia Healthcare Company, Inc. (NASDAQ: ACHC) and its investors. This examination is prompted by potential violations of federal securities laws following serious allegations concerning the company’s operational practices....

Continue Reading
Cousins Maine Lobster Dishes New Lobster Roll Flight

Updated Category News Views 7

A Bite-Sized Maine Experience Get a whiff of this: Cousins Maine Lobster is rollin' out something that'll make your taste buds do a jig. They call it the Lobster Roll Flight, and it's about to shake things up for seafood lovers everywhere. Dropping on July 1st nationwide, this offering lets foodies sample three of Cousins' star rolls—Maine, Connecticut, and Garlic...

Continue Reading
Innovative Knee Support Product Designed for Pain Relief

Updated Category News Views 250

Introducing an Innovative Knee Support Solution In today's world, many individuals suffer from knee pain, often due to issues such as arthritis or weakened quadricep muscles. Recognizing this challenge, a doctor of physical therapy and an inventive team have come together to create a groundbreaking solution called the KNEE SUPPORT. This innovative product stands out as a...

Continue Reading
Recent Forecast Changes for TELA Bio Following Third Quarter Results

Updated Category News Views 185

Recent Forecast Changes for TELA Bio TELA Bio Inc (NASDAQ: TELA) has recently reported its third-quarter earnings, which presented a mix of results. The company incurred a loss of 19 cents per share, slightly better than analysts had anticipated at 20 cents. However, TELA Bio's quarterly sales totaled $20.7 million, falling short of estimates that predicted $21.8 million....

Continue Reading